Fidelity Investments’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Buy |
93,481
+19,585
| +27% | +$435K | ﹤0.01% | 2625 |
|
|
2025
Q4 | $1.91M | Sell |
73,896
-27,928
| -27% | -$664K | ﹤0.01% | 2634 |
|
|
2025
Q3 | $2.62M | Buy |
101,824
+9,144
| +10% | +$225K | ﹤0.01% | 2445 |
|
|
2025
Q2 | $2.22M | Sell |
92,680
-53,480
| -37% | -$1.35M | ﹤0.01% | 2454 |
|
|
2025
Q1 | $3.63M | Buy |
146,160
+66,789
| +84% | +$1.6M | ﹤0.01% | 2260 |
|
|
2024
Q4 | $1.5M | Buy |
79,371
+12,206
| +18% | +$214K | ﹤0.01% | 2535 |
|
|
2024
Q3 | $1.01M | Buy |
67,165
+24,159
| +56% | +$413K | ﹤0.01% | 2601 |
|
|
2024
Q2 | $1.23M | Buy |
43,006
+863
| +2% | +$24.6K | ﹤0.01% | 2463 |
|
|
2024
Q1 | $1.23M | Sell |
42,143
-12,469
| -23% | -$383K | ﹤0.01% | 2451 |
|
|
2023
Q4 | $1.84M | Sell |
54,612
-760
| -1% | -$22.2K | ﹤0.01% | 2325 |
|
|
2023
Q3 | $1.7M | Buy |
55,372
+6,499
| +13% | +$234K | ﹤0.01% | 2325 |
|
|
2023
Q2 | $1.96M | Sell |
48,873
-961
| -2% | -$39.7K | ﹤0.01% | 2320 |
|
|
2023
Q1 | $2.03M | Buy |
49,834
+1,699
| +4% | +$67.6K | ﹤0.01% | 2360 |
|
|
2022
Q4 | $1.86M | Sell |
48,135
-1,089
| -2% | -$53K | ﹤0.01% | 2396 |
|
|
2022
Q3 | $2.62M | Buy |
49,224
+481
| +1% | +$26.7K | ﹤0.01% | 2360 |
|
|
2022
Q2 | $2.84M | Buy |
48,743
+2,559
| +6% | +$168K | ﹤0.01% | 2395 |
|
|
2022
Q1 | $3.52M | Buy |
46,184
+45,840
| +13,326% | +$3.06M | ﹤0.01% | 2454 |
|
|
2021
Q4 | $21K | Buy |
344
+278
| +421% | +$15.3K | ﹤0.01% | 3448 |
|
|
2021
Q3 | $4K | Buy |
66
+4
| +6% | +$231 | ﹤0.01% | 3857 |
|
|
2021
Q2 | $4K | Sell |
62
-1
| -2% | -$63 | ﹤0.01% | 3789 |
|
|
2021
Q1 | $4K | Buy |
63
+7
| +13% | +$500 | ﹤0.01% | 3602 |
|
|
2020
Q4 | $3K | Sell |
56
-138,427
| -100% | -$8.11M | ﹤0.01% | 3539 |
|
|
2020
Q3 | $8.32M | Buy |
138,483
+138,427
| +247,191% | +$8.04M | ﹤0.01% | 1889 |
|
|
2020
Q2 | $3K | Buy |
+56
| New | +$2.34K | ﹤0.01% | 3334 |
|
|
2020
Q1 | – | Sell |
-40
| Closed | -$2K | – | 4090 |
|
|
2019
Q4 | $2K | Buy |
+40
| New | +$1.7K | ﹤0.01% | 3569 |
|
|
2018
Q4 | – | Sell |
-125
| Closed | -$6K | – | 3972 |
|
|
2018
Q3 | $6K | Buy |
+125
| New | +$5.4K | ﹤0.01% | 3228 |
|
|
2018
Q1 | – | Sell |
-311,919
| Closed | -$14.2M | – | 2721 |
|
|
2017
Q4 | $14.2M | Sell |
311,919
-152,800
| -33% | -$6.06M | ﹤0.01% | 1838 |
|
|
2017
Q3 | $17.4M | Sell |
464,719
-156,400
| -25% | -$6.29M | ﹤0.01% | 1741 |
|
|
2017
Q2 | $29.6M | Sell |
621,119
-257,600
| -29% | -$12M | ﹤0.01% | 1517 |
|
|
2017
Q1 | $40.1M | Sell |
878,719
-875,900
| -50% | -$37.9M | 0.01% | 1426 |
|
|
2016
Q4 | $56.7M | Sell |
1,754,619
-2,546,235
| -59% | -$85M | 0.01% | 1236 |
|
|
2016
Q3 | $147M | Sell |
4,300,854
-1,266,234
| -23% | -$49.6M | 0.02% | 804 |
|
|
2016
Q2 | $188M | Buy |
5,567,088
+892,511
| +19% | +$43.9M | 0.03% | 693 |
|
|
2016
Q1 | $248M | Buy |
4,674,577
+749,040
| +19% | +$43.8M | 0.03% | 550 |
|
|
2015
Q4 | $301M | Buy |
3,925,537
+938,039
| +31% | +$53.1M | 0.04% | 478 |
|
|
2015
Q3 | $123M | Sell |
2,987,498
-538,408
| -15% | -$33M | 0.02% | 873 |
|
|
2015
Q2 | $249M | Buy |
3,525,906
+202,073
| +6% | +$15.9M | 0.03% | 585 |
|
|
2015
Q1 | $295M | Buy |
3,323,833
+134,611
| +4% | +$13.7M | 0.04% | 516 |
|
|
2014
Q4 | $283M | Sell |
3,189,222
-1,915
| -0.1% | -$181K | 0.04% | 511 |
|
|
2014
Q3 | $309M | Buy |
3,191,137
+84,355
| +3% | +$8.21M | 0.04% | 462 |
|
|
2014
Q2 | $285M | Sell |
3,106,782
-30,438
| -1% | -$2.32M | 0.04% | 513 |
|
|
2014
Q1 | $220M | Sell |
3,137,220
-544,400
| -15% | -$37M | 0.03% | 615 |
|
|
2013
Q4 | $212M | Buy |
3,681,620
+199,027
| +6% | +$10.5M | 0.03% | 611 |
|
|
2013
Q3 | $167M | Buy |
3,482,593
+787,065
| +29% | +$28.7M | 0.03% | 703 |
|
|
2013
Q2 | $78.2M | Buy |
+2,695,528
| New | +$78M | 0.01% | 1032 |
|
Other funds holding PCRX
DPCM
VPM
VCM
